ContractSeventh Amendment and Termination Agreement • July 7th, 2016 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS SEVENTH AMENDMENT AND TERMINATION AGREEMENT (the “Seventh Amendment”) is entered into on this 30th day of June, 2016 (the “Amendment Date”) by and between Amphastar Pharmaceuticals, Inc., a Delaware Corporation, (“Amphastar”) and Actavis Laboratories FL, Inc. (f/k/a Watson Laboratories, Inc. – Florida and as Andrx Pharmaceuticals, Inc.) (“Actavis” or “Purchaser”).
